On lupus, vitamin D and leukopenia

Area of Science:

• Immunology
• Endocrinology
• Rheumatology

Background:

• Vitamin D plays a role in immune regulation beyond its calcemic effects.
• Vitamin D's influence on immune function suggests a potential role in autoimmune diseases like systemic lupus erythematosus (SLE).

Purpose of the Study:

• To determine the prevalence of vitamin D deficiency in SLE patients.
• To investigate the association between vitamin D levels and clinical, serological, and treatment characteristics of SLE.
• To examine the relationship between vitamin D status and SLE disease activity.

Main Methods:

• Serum 25-hydroxyvitamin D3 levels were quantified in 153 SLE patients and 85 controls.
• Clinical, serological, and treatment data were collected via chart review.
• Blood cell counts and SLE Disease Activity Index (SLEDAI) were measured concurrently with vitamin D levels.

Main Results:

• SLE patients demonstrated significantly lower vitamin D levels than controls (p=0.03).
• Univariate analysis revealed associations between low vitamin D and leukopenia (p=0.02), cyclophosphamide use (p=0.007), and methotrexate use (p=0.03).
• A negative correlation was observed with prednisone dosage (p=0.003), and leukopenia remained an independent association in multiple regression (B=4.04; p=0.02).

Conclusions:

• Systemic lupus erythematosus patients exhibit a higher prevalence of vitamin D deficiency compared to healthy controls.
• Vitamin D deficiency in SLE is associated with leukopenia (specifically granulocytopenia), not overall disease activity.
• These findings highlight a potential link between vitamin D status and specific hematological parameters in SLE.